Idera Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Aceragen

01/04/2022 10:14

* Idera Pharmaceuticals Inc  IDRA.OQ  reported a quarterly
adjusted loss of 8 cents​​ per share for the quarter ended in
December. The lone analyst forecast for the quarter was for a
loss of 11 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Idera Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 8 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Idera Pharmaceuticals Inc shares had held steady so far
this
quarter and lost 12.3% so far this year.
    * The company reported a quarterly loss of $4.12 million.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated April 1 at 09:13 a.m.  ​All
figures in US dollars unless otherwise stated